CardioNerds
The CardioNerds—Amit Goyal, MD, and Daniel Ambinder, MD—cover cardiology concepts in an engaging format that features leaders in the industry, as well as up-and-coming voices in residency and fellowship. They aim to improve health equitably by providing timely and insightful cardiovascular health news.
The CardioNerds and Dr. Mark Drazner discuss the correct heart failure status for a 50-year-old woman with a history of CHF.
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair.
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
The CardioNerds and colleagues from MedStar Health discuss an usual case of cobalt cardiomyopathy.
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest updates from DocWire News experts, including the CardioNerds.
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.